![]() |
![]() |
|
|
Forward to a colleague |
||
Access Full Stories For the first time, scientists have found a way to target viral antigens deep inside a cancer tumour, and the result is a new therapy that could treat or even prevent the disease... Read Cells caught in a 'tractor beam' US researchers have developed a 'tractor beam' that that can pick up, hold and move individual cells around a microchip surface - paving the way for more sensitive biological devices... Read GSK blocks new patent rules Just a day before they were due to come into force, GlaxoSmithKline has won a court case to block controversial changes to patent rules... Read Gene Logic drops genomics and name for drug repositioning After selling of its genomics business to Ocimum Biosolutions, Gene Logic is to change its name to Ore Pharmaceuticals as it looks to mine out new indications for drugs... Read Nikon halves imaging time with new integrated microscope Nikon has launched a new inverted microscope range that promises to more than half the time of an imaging experiment while enabling more simultaneous applications... Read |
|||||||||||||||||
All News Headlines for: November | October | September |
|||||||||||||||||
![]() Have you got problems with aching hands in your lab? Lab professionals have twice as much upper limb disorders (URLD) as employees in general. The risk of Repetitive Strain Injury (RSI) increases, when pipetting over 1.5 hours/day. The strain will also have a negative impact on the accuracy and precision. Read more..... Click Here | |||||||||||||||||
|
Related Industry News Future of satraplatin uncertain GPC Biotech has met another obstacle in its path towards satraplatin approval after the German company announced disappointing and unexpected results in its Phase III trial... Read Genentech Avastin decision 'hard to overlook' Despite Genentech's recent decision to push out the cut-off date to ban the sale of cancer drug Avastin (bevacizumab) to compounding pharmacies in the US to restrict off-label use, ophthalmologists still find the... Read UK updates clinical trial negotiation system to include CROs An update to the contract negotiation system for hospital-based clinical trials has come into play in the UK - in a further effort to take some of the pain out of the process and speed up trial start-up times... Read Parexel profits perky in Q1 Parexel has seen its profits remain perky during its first financial quarter of 2008... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||